CANDIDA UTILIS DOUBLE GENE CO-EXPRESSION STRAIN FOR HYDROLYZING PROTEIN COMPONENTS IN KITCHEN WASTE AND CONSTRUCTION METHOD THEREOF

20220251583 · 2022-08-11

    Inventors

    Cpc classification

    International classification

    Abstract

    The present invention relates to the fields of genetic engineering and fermentation engineering, and provides a Candida utilis double gene co-expression strain for hydrolyzing protein components in kitchen waste, in which the Candida utilis double gene co-expression strain is constructed by integrating carboxypeptidases and endoprotease genes through a Candida utilis expression vector onto a Candida utilis genome. The present invention further provides a Candida utilis double gene co-expression strain capable of degrading kitchen waste, specifically degrading the protein components in the kitchen waste, and decomposing and transforming the proteins into small peptides and amino acids.

    Claims

    1. A Candida utilis double gene co-expression strain for hydrolyzing a protein component in kitchen waste, wherein the Candida utilis double gene co-expression strain is constructed by integrating a carboxypeptidase and an endoprotease gene through a Candida utilis expression vector onto a Candida utilis genome.

    2. The Candida utilis double gene co-expression strain for hydrolyzing a protein component in kitchen waste according to claim 1, wherein the Candida utilis expression vector is a Candida utilis polygenic co-expression vector.

    3. The Candida utilis double gene co-expression strain for hydrolyzing a protein component in kitchen waste according to claim 1, wherein the Candida utilis expression vector is GAP-pepA-TEF1-pepF.

    4. A construction method of the Candida utilis double gene co-expression strain for hydrolyzing protein components in kitchen waste according to claim 1, comprising steps of: S1: ligating an endoprotease gene pepA to an expression vector pcGAPGA; S2: ligating a carboxypeptidase gene pepF to an expression vector pcTEF1GA; S3: obtaining a carboxypeptidase gene pepF expression cassette; S4: linearizing an expression vector pcGAPGA-pepA; S5: ligating the above carboxypeptidase gene expression cassette to an expression vector pcGAFGA-pepA to obtain a co-expression vector containing both carboxypeptidase and endoprotease gene; and S6: cutting and linearizing the recombinant double gene co-expression vector obtained from the above construction by restriction endonuclease SacI, transforming the Candida utilis, and constructing a genetic recombinant Candida utilis double gene co-expression strain.

    5. The construction method of the Candida utilis double gene co-expression strain for hydrolyzing protein components in kitchen waste according to claim 4, wherein the co-expression vector containing both carboxypeptidase and endoprotease gene in step S5 is GAP-pepA-TEF1-pepF.

    6. The construction method of the Candida utilis double gene co-expression strain for hydrolyzing protein components in kitchen waste according to claim 4, further comprising: hydrolyzing protein components in kitchen waste by the recombinant Candida utilis double gene co-expression strain.

    7. The construction method of the Candida utilis double gene co-expression strain for hydrolyzing protein components in kitchen waste according to claim 4, wherein the transformation in step S6 comprises a transformation using an electrotransformation method, a freezing method, or a chemical reagent method.

    8. The construction method of the Candida utilis double gene co-expression strain for hydrolyzing protein components in kitchen waste according to claim 4, wherein the endoprotease in step S1 is endoprotease pepA in Aspergillus niger, and the carboxypeptidase in step S2 is carboxypeptidase pepF in Aspergillus niger.

    Description

    BRIEF DESCRIPTION OF THE DRAWINGS

    [0026] FIG. 1 shows ligating an endoprotease gene pepA and a vector pMD19-T, transforming bacteria solution DH5a, and performing PCR identification.

    [0027] FIG. 2 shows ligating a carboxypeptidase gene pepF and the vector pMD19-T, transforming the bacteria solution DH5a, and performing the PCR identification.

    [0028] FIG. 3 shows ligating the endoprotease gene pepA and an expression vector pcGAPGA, and performing positive identification.

    [0029] FIG. 4 shows ligating the carboxypeptidase gene pepF and an expression vector pcTEF1GA, and performing positive identification.

    [0030] FIG. 5 is a pepF expression cassette gene.

    [0031] FIG. 6 shows linearizing a pcGAPGA-pepA expression vector BamHI.

    [0032] FIG. 7 shows performing inverse PCR on the linearized pcGAPGA-pepA.

    [0033] FIG. 8 shows ligating a pepF expression cassette and a pcGAPGA-pepA vector after inverse PCR, transforming the DH5a, and performing the positive identification.

    [0034] FIG. 9 shows linearizing a double gene expression vector.

    [0035] FIG. 10 shows electrotransforming Candida utilis and performing positive identification.

    [0036] FIG. 11 is a growth curve for recombinant Candida utilis TGCE protease activity.

    [0037] FIG. 12 shows a recombinant plasmid construction process of pcGAPGA-pepA and pcTEF1GA-pepF.

    [0038] FIG. 13 is a growth curve for recombinant Candida utilis scTEF1-pepF protease activity.

    [0039] FIG. 14 is a growth curve for recombinant Candida utilis cuGAP-pepA protease activity.

    [0040] FIG. 15 is a construction process of double gene co-expression vector GAP-pepA-TEF1-pepF.

    [0041] FIG. 16 is a construction process of triple-gene co-expression vector GAP-pepA-TEF1-YPDF-HXT7-pepF.

    [0042] FIG. 17 is a growth curve for triple-gene co-expression recombinant Candida utilis protease activity.

    DETAILED DESCRIPTION

    [0043] The drawings are for illustrative purposes only and are not to be construed as limiting the present invention. For better explanation of the following embodiments, some components in the drawings may be omitted, enlarged, or reduced, and sizes of these components do not represent sizes of actual products. For those skilled in the art, it will be understood that some known structures and descriptions thereof in the drawings may be omitted.

    EMBODIMENT

    [0044] A pMD19-X recombinant plasmid was obtained by recombining an amplified target gene and a pMD19-T vector, that is, a recombinant plasmid containing a target gene X, in which X represents a pepA gene or a pepF gene. Digestion was performed on the recombinant plasmids containing pepA or pepF, while digestion was respectively performed on Candida utilis expression vectors pcGAPGA and pcTEF1GA. A pcGAPGA-pepA recombinant plasmid was obtained by ligating the expression vector pcGAPGA and the target gene pepA that were obtained after digestion. A pcTEF1GA-pepF recombinant plasmid was obtained by ligating the expression vector pcTEF1GA and the target gene pepF that were obtained after digestion. FIG. 12 shows structures of pcGAPGA and pcTEF1GA and a recombinant plasmid construction process. A recombinant Candida utilis containing carboxypeptidase pepF single gene was obtained after electrotransforming the pcTEF1GA-pepF recombinant plasmid into the Candida utilis. After being performed with biomass and protease activity determination, the recombinant strain was named scTEF1-pepF, and a graph drawn for the determination is shown in FIG. 13. A recombinant Candida utilis containing endoprotease pepA single gene was obtained after electrotransforming the pcGAPGA-pepA recombinant plasmid into the Candida utilis. After being performed with biomass and protease activity determination, the recombinant strain was named cuGAP-pepA, and a graph drawn for the determination is shown in FIG. 14. Based on the obtained expression vector pcGAPGA-pepA, an aminopeptidase gene expression cassette YPDF and a carboxypeptidase gene expression cassette pepF were obtained respectively; the YPDF gene expression cassette and the pcGAPGA-pepA expression vector were ligated and transformed to obtain an expression vector containing both aminopeptidase and endoprotease gene, which was named GAP-pepA-HXT7-YPDF; the vector and the pepF gene expression cassette were ligated and transformed to obtain a triple-gene expression vector containing aminopeptidase, carboxypeptidase and endoprotease, which was named GAP-pepA-TEF1-YPDF-HXT7-pepF. Specific construction process and structure are shown in FIG. 16. After electrotransforming the Candida utilis for biomass and protease activity determination, a graph is drawn and shown in FIG. 17.

    [0045] 1. Respective Ligation Between the Endoprotease Gene pepA Anti the Carboxypeptidase Gene pepF with Expression Vectors pcGAPCA Anti pcTEF1CA

    [0046] (1) Endoprotease pepA was ligated to expression vector pcGAPGA.

    [0047] A genome was extracted from Aspergillus niger, and a pepA fragment was obtained using a primer pepA F/R and PCR, in which the sequence of pepA fragment is shown as the SEQ ID No. 2 sequence in a sequence table. After ligation of the obtained segment and the pMD19-T vector, heat-shock transformation was performed on the DH5a E. coli for bacteria solution PCR identification, and the result is shown in FIG. 1.

    [0048] The pMD19-T vector and the pcGAPGA expression vector, which were ligated with the pepA gene, were respectively double-digested with two restriction endonucleases XhoI and XbaI, and target fragments were recovered.

    [0049] After ligation of the double-digested pepA gene and the double-digested pcGAPGA expression vector using a DNA ligase, the recombinant expression vector pcGAPGA-pepA was constructed, heat-shock transformation was performed on the DH5a E. coli for bacteria solution PCR identification, and the result is shown in FIG. 3.

    [0050] (2) The carboxypeptidase pepF was ligated to the expression vector pcTEF1GA.

    [0051] A genome was extracted from Aspergillus niger, and a pepF fragment was obtained using a primer pepF F1-R4 and overlap extension PCR, in which the sequence of pepF fragment is shown as the SEQ ID No. 1 sequence in a sequence table. After ligation of the obtained segment and the pMD19-T vector, heat-shock transformation was performed on the DH5a E. coli for bacteria solution PCR identification, and the result is shown in FIG. 2.

    [0052] The pMD19-T vector and the pcTEF1GA expression vector, which were ligated with the pepF gene, were respectively double-digested with two restriction endonucleases XhoI and XbaI, and target fragments were recovered.

    [0053] After ligation of the double-digested pepF gene and the double-digested pcTEF1GA expression vector using a DNA ligase, the recombinant expression vector pcTEF1GA-pepF was constructed, heat-shock transformation was performed on the DH5a E. coli for bacteria solution PCR identification, and the result is shown in FIG. 4.

    2. Acquisition of a pepF Expression Cassette

    [0054] Plasmids were extracted from DH5a E. coli containing the recombinant expression vector pcTEF1GA-pepF plasmid. A pepF expression cassette of a pepF gene fragment containing a TET1 promoter was obtained taking recombinant expression vector pcTEF1GA-pepF plasmid as a template and using a primer pepF casF/R and PCR amplification, and the result is shown in FIG. 5.

    3. Linearization of Recombinant Expression Vector pcGAPGA-pepA

    [0055] Plasmids were extracted from DH5a E. coli containing the recombinant expression vector pcGAPGA-pepA plasmid. Linearized treatment was performed on the recombinant vector taking recombinant expression vector pcGAPGA-pepA plasmid as a template and using restriction endonuclease BamHI. The result is shown in FIG. 6.

    [0056] To improve the effect of seamless ligation and remove disturbance to the seamless ligation by the undigested plasmid background, inverse PCR was performed on the linearized plasmid segment to obtain a final linearized recombinant expression vector pcGAPGA-pepA by taking BamHI single-digested linearized segment as a template and using a primer RpepA F/R, and the result is shown in FIG. 7.

    4. Ligation of pepF Expression Cassette with Linearized Recombinant Expression Vector pcGAPGA-pepA and Transformation of Candida utilis

    [0057] The obtained pepF expression cassette was ligated with the linearized pcGAPGA-pepA recombinant plasmid using a seamless ligation kit to obtain a recombinant dual gene expression vector GAP-pepA-TEF1-pepF, a construction process of which is shown in FIG. 15 then DH5a E. coli was transformed, positive identification of DH.5a was performed using primers pepA F/R and pepF F1/R4, and the result is shown in FIG. 8.

    [0058] Plasmids were extracted from DH5a. E. coli containing the double gene recombinant expression vector GAP-pepA-TEF1-pepF plasmid, a Candida utilis TGCE containing endoprotease pepA and carboxypeptidase pepF was obtained after linearized treatment using the restriction endonuclease Sad and transformation of the Candida utilis, the genome of Candida utilis TGCE was identified, and the result is shown in FIG. 9.

    5. Growth Curves for Double Gene Recombinant Candida utilis TGCE Protease Activity

    [0059] The recombined Candida utilis TGCE containing double genes of endoprotease and carboxypeptidase were cultured and inoculated in 100 mL of YPD culture medium with an initial inoculum size of OD=0.05, supernatant liquid was removed every 12 hours, the biomass in recombinant Candida utilis and the protease activity in the supernatant liquid were determined using a Folin method to drawn a graph, and the result is shown in FIG. 11.

    [0060] Referring to FIG. 11, it can be seen that in the growth curve for double gene Candida utilis protease activity, the OD value peaked and exceeded 30 at the 72th hour and was still above 25 for a period of time until the 94th hour, while the protease activity peaked and exceeded 14 U/mL at the 48th hour and still fluctuated within an interval of 11 to 14 U/mL between the 48th hour to the 96th hour. As to FIG. 13, that is, a growth curve for pepF single gene-containing Candida utilis protease activity, although the OD value thereof peaked and exceeded 30 at the 84th hour, a more obvious drop occurs upon reaching the peak value. The protease activity peaked only below 13 U/mL, and a significant drop occurs upon reaching the peak value and dropped below 11 U/mL at the 96th hour. Therefore, double gene has a better growth amount, and stable and higher protease activity as compared to the pepF single gene. As to FIG. 14, although the protease activity of the pepA single gene Candida utilis fluctuated within an interval of 14 to 16 U/mL after the 72th hour with high protease activity, the growth amount thereof obviously changed after the 60th hour; the high protease activity failed to produce enzyme for a longer time as growth conditions deteriorated, and thus the decrease in the amount of enzyme still leaded to unfavorable effect of enzymatic degradation. However, referring to the double gene represented in FIG. 11, although the protease activity decreased after the 48th hour, the protease activity was still at a higher level, and the growth amount remains at a higher level for a longer period of time, in which a balanced growth condition and protease activity was beneficial to significantly improve the degradation effect. As to FIG. 17, that is, a growth curve for triple-gene Candida utilis protease activity, although the protease activity thereof reached a peak value similar to that of the double gene in the present application at the 48th hour and sustained protease activity with the peak value for a period of time, the OD value thereof smoothly rose to peak and then dropped while the peak value was below 25. Therefore, it is evident that the triple gene is slow in growth rate, and that the growth amount is obviously fewer than the other single-gene or double-gene recombinant Candida utilis. Therefore, compared to single gene and triple gene, the double gene in the present application has stable and higher protease activity and growth amount, which balances strain enzyme activity and strain growth conditions, significantly increases degradation effects by unit strains, and is suitable for industrial applications.

    [0061] In the embodiments described above, the primers used are shown in Table 1, in which the letter F represents a forward primer, R represents a reverse primer, and the sequence numbers represent different primer combinations.

    TABLE-US-00001 TABLE 1 Oligonucleotides Sequence (5′.fwdarw.3′) F1 AGCTCGAGAAAAGAGAGGCTGAAGCTATGCTGTTTCGCAGTCTGTT R1 GCTTAGTCTTGTTGTTCAAGAACTG F2 CTTGAACAACAAGACTAAGCCTTACCGCGTGGAAAGC pepF R2 TTCCCACAGGTTGGTCAACCCACAGAACATTGGTGAGATTCA F3 GGTTGACCAACCTGTGGGA R3 GGGATCATATGCCAGTGCACCTTTTAGGTTGAAGTGTTCTGTATCA F4 GTGCACTGGCATATGATCCCT R4 AGTCTAGATTACAGGGTATCACGCCGG pepA F AGTTCGAAACGATGGTTGTTTTCTCTAAGAC pepA R AGTCTAGATTATCAGAACAACAAGTAAGACAACA pepF casF GACCTTCGTTTGTGCAGATCTGCACACACCATAGCT pepF casR GGATCCGCACAAACGAAG RpepA F CCCACACACCATAGCTTCAA RpepA R GCACAAACGAAGGTCTCACTT

    [0062] Obviously, the above embodiments of the present invention are merely examples for clear illustration of the technical solutions of the present invention, and are not intended to limit the implementation of the present invention. Any modification, equivalent substitution, improvement or the like within the spirit and principle of claims of the present invention should be included in the scope of the claims of the present invention.